血管紧张素转换酶抑制剂可增强肌肉力量。 - Suppr

Suppr

超能文献

ACE inhibitor bulks up muscle.

作者信息

Chamberlain Jeffrey S

出版信息

Nat Med. 2007 Feb;13(2):125-6. doi: 10.1038/nm0207-125.

DOI:10.1038/nm0207-125

PMID:17290265

Abstract

摘要

相似文献

ACE inhibitor bulks up muscle.

Nat Med. 2007 Feb;13(2):125-6. doi: 10.1038/nm0207-125.

Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states.

Nat Med. 2007 Feb;13(2):204-10. doi: 10.1038/nm1536. Epub 2007 Jan 21.

A small molecule for a large disease.

N Engl J Med. 2008 Jun 26;358(26):2829-31. doi: 10.1056/NEJMe0804008.

Intramuscular renin-angiotensin system is activated in human muscular dystrophy.

J Neurol Sci. 2009 May 15;280(1-2):40-8. doi: 10.1016/j.jns.2009.01.020. Epub 2009 Feb 20.

Angiotensin II blockade in Marfan's syndrome.

N Engl J Med. 2008 Oct 16;359(16):1732-3; author reply 1733-4.

Medicine. Frightening risk of Marfan syndrome, and potential treatment, elucidated.

Science. 2011 Apr 15;332(6027):297. doi: 10.1126/science.332.6027.297.

Studies point way to new therapeutic prospects for muscular dystrophy.

JAMA. 2007 Sep 26;298(12):1385-6. doi: 10.1001/jama.298.12.1385.

Angiotensin II receptor blockade administered after injury improves muscle regeneration and decreases fibrosis in normal skeletal muscle.

Am J Sports Med. 2008 Aug;36(8):1548-54. doi: 10.1177/0363546508315470. Epub 2008 Jun 11.

Drug shows promise for marfan syndrome.

JAMA. 2006 May 3;295(17):1990. doi: 10.1001/jama.295.17.1990.

Medicine. Old drug, new hope for Marfan syndrome.

Science. 2006 Apr 7;312(5770):36-7. doi: 10.1126/science.312.5770.36b.

引用本文的文献

Limited evidence for the usage of renin-angiotensin-aldosterone pathway blockers to prevent arthrofibrosis after total knee arthroplasty. A systematic review of clinical evidence.

J Exp Orthop. 2024 Dec 11;11(4):e70089. doi: 10.1002/jeo2.70089. eCollection 2024 Oct.

Metabolic pathways for removing reactive aldehydes are diminished in the skeletal muscle during heart failure.

Skelet Muscle. 2024 Oct 18;14(1):24. doi: 10.1186/s13395-024-00354-2.

Metabolic Pathways for Removing Reactive Aldehydes are Diminished in Atrophic Muscle During Heart Failure.

Res Sq. 2023 Nov 21:rs.3.rs-3621159. doi: 10.21203/rs.3.rs-3621159/v1.

Becker muscular dystrophy with dilated cardiomyopathy: A case report.

Clin Case Rep. 2021 Sep 18;9(9):e04777. doi: 10.1002/ccr3.4777. eCollection 2021 Sep.

Agent-based model provides insight into the mechanisms behind failed regeneration following volumetric muscle loss injury.

PLoS Comput Biol. 2021 May 10;17(5):e1008937. doi: 10.1371/journal.pcbi.1008937. eCollection 2021 May.

Pharmacotherapies for the Treatment of Eosinophilic Esophagitis: State of the Art Review.

Drugs. 2019 Sep;79(13):1419-1434. doi: 10.1007/s40265-019-01173-2.

Role of Oxidative Stress as Key Regulator of Muscle Wasting during Cachexia.

Oxid Med Cell Longev. 2018 Mar 28;2018:2063179. doi: 10.1155/2018/2063179. eCollection 2018.

Therapeutic strategies for preventing skeletal muscle fibrosis after injury.

Front Pharmacol. 2015 Apr 21;6:87. doi: 10.3389/fphar.2015.00087. eCollection 2015.

Treatment of dystrophin cardiomyopathies.

Nat Rev Cardiol. 2014 Mar;11(3):168-79. doi: 10.1038/nrcardio.2013.213. Epub 2014 Jan 14.

Angiotensin II induced catabolic effect and muscle atrophy are redox dependent.

Biochem Biophys Res Commun. 2011 Jun 3;409(2):217-21. doi: 10.1016/j.bbrc.2011.04.122. Epub 2011 May 6.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

ACE inhibitor bulks up muscle.

Nat Med. 2007 Feb;13(2):125-6. doi: 10.1038/nm0207-125.

Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states.

Nat Med. 2007 Feb;13(2):204-10. doi: 10.1038/nm1536. Epub 2007 Jan 21.

A small molecule for a large disease.

N Engl J Med. 2008 Jun 26;358(26):2829-31. doi: 10.1056/NEJMe0804008.

Intramuscular renin-angiotensin system is activated in human muscular dystrophy.

J Neurol Sci. 2009 May 15;280(1-2):40-8. doi: 10.1016/j.jns.2009.01.020. Epub 2009 Feb 20.

Angiotensin II blockade in Marfan's syndrome.

N Engl J Med. 2008 Oct 16;359(16):1732-3; author reply 1733-4.

Medicine. Frightening risk of Marfan syndrome, and potential treatment, elucidated.

Science. 2011 Apr 15;332(6027):297. doi: 10.1126/science.332.6027.297.

Studies point way to new therapeutic prospects for muscular dystrophy.

JAMA. 2007 Sep 26;298(12):1385-6. doi: 10.1001/jama.298.12.1385.

Angiotensin II receptor blockade administered after injury improves muscle regeneration and decreases fibrosis in normal skeletal muscle.

Am J Sports Med. 2008 Aug;36(8):1548-54. doi: 10.1177/0363546508315470. Epub 2008 Jun 11.

Drug shows promise for marfan syndrome.

JAMA. 2006 May 3;295(17):1990. doi: 10.1001/jama.295.17.1990.

Medicine. Old drug, new hope for Marfan syndrome.

Science. 2006 Apr 7;312(5770):36-7. doi: 10.1126/science.312.5770.36b.

引用本文的文献

Limited evidence for the usage of renin-angiotensin-aldosterone pathway blockers to prevent arthrofibrosis after total knee arthroplasty. A systematic review of clinical evidence.

J Exp Orthop. 2024 Dec 11;11(4):e70089. doi: 10.1002/jeo2.70089. eCollection 2024 Oct.

Metabolic pathways for removing reactive aldehydes are diminished in the skeletal muscle during heart failure.

Skelet Muscle. 2024 Oct 18;14(1):24. doi: 10.1186/s13395-024-00354-2.

Metabolic Pathways for Removing Reactive Aldehydes are Diminished in Atrophic Muscle During Heart Failure.

Res Sq. 2023 Nov 21:rs.3.rs-3621159. doi: 10.21203/rs.3.rs-3621159/v1.

Becker muscular dystrophy with dilated cardiomyopathy: A case report.

Clin Case Rep. 2021 Sep 18;9(9):e04777. doi: 10.1002/ccr3.4777. eCollection 2021 Sep.

Agent-based model provides insight into the mechanisms behind failed regeneration following volumetric muscle loss injury.

PLoS Comput Biol. 2021 May 10;17(5):e1008937. doi: 10.1371/journal.pcbi.1008937. eCollection 2021 May.

Pharmacotherapies for the Treatment of Eosinophilic Esophagitis: State of the Art Review.

Drugs. 2019 Sep;79(13):1419-1434. doi: 10.1007/s40265-019-01173-2.

Role of Oxidative Stress as Key Regulator of Muscle Wasting during Cachexia.

Oxid Med Cell Longev. 2018 Mar 28;2018:2063179. doi: 10.1155/2018/2063179. eCollection 2018.

Therapeutic strategies for preventing skeletal muscle fibrosis after injury.

Front Pharmacol. 2015 Apr 21;6:87. doi: 10.3389/fphar.2015.00087. eCollection 2015.

Treatment of dystrophin cardiomyopathies.

Nat Rev Cardiol. 2014 Mar;11(3):168-79. doi: 10.1038/nrcardio.2013.213. Epub 2014 Jan 14.

Angiotensin II induced catabolic effect and muscle atrophy are redox dependent.

Biochem Biophys Res Commun. 2011 Jun 3;409(2):217-21. doi: 10.1016/j.bbrc.2011.04.122. Epub 2011 May 6.